Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease 2022-01-12 07:59
PostEra announces $260M multi-target strategic AI Lab collaboration with Pfizer 2022-01-11 22:00
SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study 2022-01-11 20:27
Latest Study Shows Encouraging Results of CanSinoBIO's Inhaled COVID-19 Vaccine as Heterologous Booster 2022-01-11 15:15
MGI Aims to Boost its Market Share through Participation at Expo 2020 Dubai's Guangdong Week 2022-01-11 14:00
Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy 2022-01-11 09:30
Cyclone Robotics Was Recognized as a "Strong Performer" by the "Gartner Peer Insights 'Voice of the Customer': Robotic Process Automation" Report 2022-01-10 22:01
JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building 2022-01-10 09:30
CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China 2022-01-09 10:09
Virtue Diagnostics closes $100 million Series B Funding 2022-01-06 11:01
MingMed to Present at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-06 09:00
Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation 2022-01-05 17:00
Antengene to Present at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-05 12:50
IND Approved for Pivotal Clinical Study of HER2 Bispecific Antibody KN026 Combined with Chemotherapy in Gastric Cancer 2022-01-05 11:49
COVID-19 Oral Vaccine and Antibody Booster: B. subtilis Spores, Biotechnology Breakthrough by DreamTec 2022-01-05 10:00
CAI Announces CEO Succession 2022-01-04 22:33
Molecular Stethoscope, Inc. establishes new Corporate Headquarters and Research & Development Laboratories in South San Francisco and appoints Gajus Worthington to its Board of Directors 2022-01-04 19:00
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002 2022-01-04 10:00
Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer 2022-01-04 08:00
Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads Investment in Xuanzhu Biopharm 2022-01-03 14:24
1 88 89 90 91 92 211